Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma: A case study.

Bibliographic Details
Title: Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma: A case study.
Authors: Bergengruen, Paula Maria, Hernaíz Driever, Pablo, Budach, Volker, Zips, Daniel, Grün, Arne
Source: Strahlentherapie und Onkologie; Aug2023, Vol. 199 Issue 8, p773-777, 5p
Abstract: Purpose: Concomitant chemoradiation followed by repeat (dose-deescalated) irradiation has become standard of care in treating childhood diffuse intrinsic pontine glioma (DIPG) during first line treatment and at first progression. Progression after re-irradiation (re-RT) is in most cases symptomatic and either treated systemically with chemotherapy or new innovative approaches including targeted therapy. Alternatively, the patient receives best supportive care. Data on second re-irradiation in DIPG patients with second progression and good performance status are sparse. This is a case report of second short-term re-irradiation to shed further light on this option. Methods: Retrospective case report of a 6-year-old boy with DIPG receiving a second course of re-irradiation (with 21.6 Gy) as part of an individual multimodal approach in a patient with very low symptom burden. Results: The second course of re-irradiation was feasible and well tolerated. No acute neurological symptoms or radiation-induced toxicity occurred. Overall survival was 24 months after initial diagnosis. Conclusion: A second course of re-irradiation can be an additional tool in patients with progressive disease after first- and second-line irradiation. It is unclear whether and to what extent it contributes to progression-free survival prolongation and if—since our patient was asymptomatic—progression-associated neurological deficits can be alleviated. [ABSTRACT FROM AUTHOR]
Copyright of Strahlentherapie und Onkologie is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:01797158
DOI:10.1007/s00066-023-02057-x
Published in:Strahlentherapie und Onkologie
Language:English